Products for Research Use Only
RegisterLogin

MRTX849

CAT: 0013-GTR19167073-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19167073-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Adagrasib (MRTX849) is a covalent, orally bioavailable inhibitor that selectively targets the inactive, GDP-bound form of KRAS G12C, blocking its oncogenic signaling. It demonstrates potent anti-tumor activity in both cellular assays and in vivo models, making it a key tool for oncology research targeting KRAS-driven cancers.
CAS Number
2326521-71-3
Product Name Alternative
Adagrasib
Field of Research
Immunology & Inflammation
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
CN1CCC[C@H]1COc1nc2CN (CCc2c (n1) N1CCN ([C@@H] (CC#N) C1) C (=O) C (F) =C) c1cccc2cccc (Cl) c12
Molecular Formula
C32H35ClFN7O2
Molecular Weight
604.1
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2-[ (2S) -4-[7- (8-Chloronaphthalen-1-yl) -2-[[ (2S) -1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1- (2-fluoroprop-2-enoyl) piperazin-2-yl]acetonitrile

Chemical Information

Adagrasib

Adagrasib (MRTX849) is an oral, small-molecule KRAS inhibitor developed by Mirati Therapeutics. KRAS mutations are highly common in cancer and account for approximately 85% of all RAS family mutations.

CAS Number2326521-71-3
PubChem CID138611145
IUPAC Name2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile
Molecular FormulaC32H35ClFN7O2
Molecular Weight604.1
XLogP5
Topological Polar Surface Area88.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Heavy Atom Count43
Formal Charge0
Complexity1060
SMILES
CN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F
InChI
InChI=1S/C32H35ClFN7O2/c1-21(34)31(42)41-17-16-40(18-23(41)11-13-35)30-25-12-15-39(28-10-4-7-22-6-3-9-26(33)29(22)28)19-27(25)36-32(37-30)43-20-24-8-5-14-38(24)2/h3-4,6-7,9-10,23-24H,1,5,8,11-12,14-20H2,2H3/t23-,24-/m0/s1
InChIKey
PEMUGDMSUDYLHU-ZEQRLZLVSA-N
Chemical Structure
2D Structure
2D structure of Adagrasib
CAS: 2326521-71-3
CID: 138611145
Formula: C32H35ClFN7O2
MW: 604.1
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight604.1
XLogP35
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Exact Mass603.2524792
Monoisotopic Mass603.2524792
Topological Polar Surface Area88.8 Ų
Heavy Atom Count43
Formal Charge0
Complexity1060
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
BM177692-01MRTX849
S8884-100mgAdagrasib (MRTX849)
HY-139402-01MRTX849 acid
T40156MRTX849 analog 24
A16482-100Adagrasib (MRTX849) 100mg
MBS5800476MRTX849 ethoxypropanoic acid
A16482-500Adagrasib (MRTX849) 500mg
A16482-50Adagrasib (MRTX849) 50mg
A16482-5Adagrasib (MRTX849) 5mg

Popular Products